# Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)

> **NCT00738972** · PHASE3 · TERMINATED · sponsor: **Fundación Lindavista del Corazón AC** · enrollment: 12 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan
- **DRUG:** pravastatin
- **DRUG:** simvastatin
- **DRUG:** ezetimibe (+) simvastatin

## Key facts

- **NCT ID:** NCT00738972
- **Lead sponsor:** Fundación Lindavista del Corazón AC
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Study terminated early due to sample size, not possible to perform further statistical analysis.
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00738972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00738972, "Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00738972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*